Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Thompson

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Healthcare Executive|January 9, 2016
Going green in healthcare. With its energy-saving initiatives, Gundersen Health System has become energy independentJeffrey Thompson, Michael Allen
Peerj|July 15, 2025
An R package for survival-based gene set enrichment analysisXiaoxu Deng, Jeffrey Thompson
Gynecologic Oncology|July 10, 2024
Elucidating the influences of social determinants of health on perceived overall health among African American/Black and Hispanic ovarian cancer survivors using the NIH All of Us Research ProgramDiane E Mahoney, Rishav Mukherjee, Jeffrey Thompson
Frontiers in Endocrinology|September 22, 2018
Real Talk: The Inter-play Between the mTOR, AMPK, and Hexosamine Biosynthetic Pathways in Cell SignalingGentry K Cork, Jeffrey Thompson, Chad Slawson
Clinical Therapeutics|July 25, 2006
Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteersMona Darwish, Kenneth Tempero, Mary Kirby, et al.
Clinical Pharmacokinetics|December 24, 2005
Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteersMona Darwish, Kenneth Tempero, Mary Kirby, et al.
Neurorehabilitation|February 25, 2022
Intensive rehabilitation for functional motor disorders (FMD) in the United States: A reviewGinger Polich, Jeffrey Thompson, Ivan Molton, et al.
Urology|June 23, 2023
Evaluating Financial Toxicity in Urologic PracticeVassili Glazyrine, Daniel Au, Jared Starkey, et al.
Translational Stroke Research|August 9, 2016
Rodent Models of Vascular Cognitive ImpairmentYi Yang, Shihoko Kimura-Ohba, Jeffrey Thompson, et al.
The Russell Sage Foundation Journal of the Social Sciences : RSF|August 21, 2018
Inequality and Mobility using Income, Consumption, and Wealth for the Same IndividualsJonathan Fisher, David Johnson, Jonathan Latner, et al.
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Healthcare Executive|January 9, 2016
Going green in healthcare. With its energy-saving initiatives, Gundersen Health System has become energy independentJeffrey Thompson, Michael Allen
Peerj|July 15, 2025
An R package for survival-based gene set enrichment analysisXiaoxu Deng, Jeffrey Thompson
Gynecologic Oncology|July 10, 2024
Elucidating the influences of social determinants of health on perceived overall health among African American/Black and Hispanic ovarian cancer survivors using the NIH All of Us Research ProgramDiane E Mahoney, Rishav Mukherjee, Jeffrey Thompson
Frontiers in Endocrinology|September 22, 2018
Real Talk: The Inter-play Between the mTOR, AMPK, and Hexosamine Biosynthetic Pathways in Cell SignalingGentry K Cork, Jeffrey Thompson, Chad Slawson
Clinical Therapeutics|July 25, 2006
Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteersMona Darwish, Kenneth Tempero, Mary Kirby, et al.
Clinical Pharmacokinetics|December 24, 2005
Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteersMona Darwish, Kenneth Tempero, Mary Kirby, et al.
Neurorehabilitation|February 25, 2022
Intensive rehabilitation for functional motor disorders (FMD) in the United States: A reviewGinger Polich, Jeffrey Thompson, Ivan Molton, et al.
Urology|June 23, 2023
Evaluating Financial Toxicity in Urologic PracticeVassili Glazyrine, Daniel Au, Jared Starkey, et al.
Translational Stroke Research|August 9, 2016
Rodent Models of Vascular Cognitive ImpairmentYi Yang, Shihoko Kimura-Ohba, Jeffrey Thompson, et al.
The Russell Sage Foundation Journal of the Social Sciences : RSF|August 21, 2018
Inequality and Mobility using Income, Consumption, and Wealth for the Same IndividualsJonathan Fisher, David Johnson, Jonathan Latner, et al.
Pageof 9